Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe study's record history gains a new revision entry for v3.7.0, while the older v3.6.6 entry is removed from the history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s revision label changed from v3.6.5 to v3.6.6, indicating a new build of the study history interface.SummaryDifference0.1%

- Check75 days agoChange DetectedThe history now includes a new Revision: v3.6.5 entry, replacing the previous Revision: v3.6.4. This reflects a minor administrative update to the page's revision record.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision: v3.6.4 has been added to the study history, replacing the previous v3.6.3. This is an administrative update to the record's metadata and does not alter study data or outcomes.SummaryDifference0.0%

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.